Gurobi Optimization Signs Partnership with Air France for Its Operations Research Projects
30.9.2019 16:00:00 EEST | Business Wire | Press release
Gurobi Optimization, LLC today announced Air France has chosen Gurobi as the preferred optimization solver for its operations research projects. Air France will use the Gurobi Optimizer in its projects such as revenue management, ground staff planning, flight scheduling, flight crew planning, and engine maintenance. Air France expects to benefit from significant cost savings, increased profitability, and enhanced passenger and crew satisfaction through the use of the Gurobi Optimizer.
The Gurobi mathematical programming solver is used by airlines and transportation companies around the world to solve complex optimization problems. Optimization technology is used to manage the complex tradeoffs that arise whenever multiple activities compete for limited resources, often in situations where demand can vary significantly. The use of optimization in the airline industry has saved companies billions of dollars and driven significant gains in customer satisfaction levels.
Integrated into the Air France IT department, the mission of the Operations Research department is to optimize the operation of all company activities by transforming data into smart decisions. It thus contributes to the strategy of the company, through the improvement of the company's commercial and operational performance. Air France's Operations Research department is one of the most important in France and in the air transport sector. Employees are simultaneously consultants, innovators and developers. They work on various company domains, from maintenance to customer relations as well as flight crews.
“For several years, Air France's Operations Research department has been able to measure the efficiency of Gurobi’s solvers as part of its projects. I am pleased to be able to strengthen our partnership with Gurobi today, with a view to our future needs,” said Jean-Christophe Lalanne, Air France KLM CIO.
“Gurobi is pleased that Air France has chosen Gurobi Optimization for its operations research projects,” said Dr. Edward Rothberg, CEO, Gurobi Optimization. “Gurobi is seeing more and more airlines and airports switch to Gurobi technology because of our cutting-edge performance and industry-leading technical support. Our objective is simple: to build technologies that will contribute to our customers’ success in an increasingly complex global market.”
About Air France
Air France, airline of French inspiration, with high standards and a caring attitude, turns the flight into a moment of real pleasure on all its daily operations in France, Europe and worldwide.
Air France-KLM is the leading Group in terms of international traffic on departure from Europe. It offers its customers access to a network covering 314 destinations in 116 countries thanks to Air France, KLM Royal Dutch Airlines and Transavia. With a fleet of 548 aircraft and 101.4 million passengers carried in 2018, Air France-KLM operates up to 2,300 daily flights, mainly from its hubs at Paris-Charles de Gaulle and Amsterdam-Schiphol. Its Flying Blue loyalty program is one of the leaders in Europe with over 15 million members.
Together with its partners Delta Air Lines and Alitalia, Air France and KLM operates the largest transatlantic joint venture with more than 275 daily flights. The group also offers cargo transport and aeronautical maintenance solutions. Air France and KLM are also members of the SkyTeam alliance which has 19 member airlines, offering customers access to a global network of over 14,500 daily flights to more than 1,150 destinations in more than 175 countries.
corporate.airfrance.com
@AFnewsroom
About Gurobi Optimization
Gurobi (http://www.gurobi.com) is in the business of helping companies make better decisions. In addition to providing the fastest math programming solver, as well as tools for distributed optimization and optimization in the cloud, the company is known for its outstanding support and flexible licensing.
The Gurobi Optimizer is a state-of-the-art solver for linear programming (LP), quadratic programming (QP), quadratically constrained programming (QCP), mixed-integer linear programming (MILP), mixed-integer quadratic programming (MIQP), and mixed-integer quadratically constrained programming (MIQCP). Gurobi was designed from the ground up to exploit modern architectures and multi-core processors, using the most advanced implementations of the latest algorithms. Founded in 2008, Gurobi Optimization is based in Beaverton, OR (+1 713 871 9341).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190930005180/en/
Contact information
Gurobi Optimization
Isela Warner
Gurobi Optimization, LLC
775-771-2826
warner@gurobi.com
Air France Press Office:
+ 33 (0)1 41 56 56 00
corporate.airfrance.com
Twitter: @AFnewsroom
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease2.5.2026 00:28:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 19:08:00 EEST | Press release
A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release
Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom